article thumbnail

Analysis of U.S. Food and Drug Administration Draft Guidance on Clinical Trials with Psychedelic Drugs

Healthcare Law Insights blog

On June 23, 2023 the U.S. Food and Drug Administration (FDA) published a draft guidance document with foundational considerations for researchers that are developing psychedelic drugs for the treatment of medical conditions. All comments should be identified with the docket number FDA-2023-D-1987.

article thumbnail

Jumpstarting Goals of Care Convos: Erin Kross, Bob Lee, and Ruth Engelberg

GeriPal

They found a difference of 4% in documented goals of care discussions. Randy died February 26, 2023. At its heart, it’s always been a brief, hopefully one page document that can be delivered to clinicians and or patients to get them thinking about topics related to goals of care discussions. Is 4% meaningful? Erin: Yeah.

Document 156